Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Austria Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20081
20101
20121
20131
20161
20181
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Ulm3
Boehringer Ingelheim2
European Organisation for Research and Treatment of Cancer - EORTC2
Astex Pharmaceuticals, Inc.1
Celgene1
Cogent Biosciences, Inc.1
Novartis Pharmaceuticals1
Taiho Oncology, Inc.1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute13
Leukemia4
Myelodysplastic Syndromes3
Leukemia, Myelomonocytic, Chronic2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Disease1
Hematologic Diseases1
Hematologic Neoplasms1
Hypersensitivity1
Immune Complex Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.